Resumen de acción GUFICBIO
Gufic Biosciences Limited fabrica y comercializa principios activos farmacéuticos (API), productos farmacéuticos genéricos y servicios relacionados en India, África, Asia, Europa, Australia, Norteamérica, Sudamérica y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de Gufic Biosciences Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹315.00 |
| 52 Week High | ₹364.90 |
| 52 Week Low | ₹195.70 |
| Beta | 0.82 |
| 1 Month Change | -2.64% |
| 3 Month Change | 6.85% |
| 1 Year Change | 59.09% |
| 3 Year Change | 68.54% |
| 5 Year Change | 288.89% |
| Change since IPO | 964.19% |
Noticias y actualizaciones recientes
Recent updates
We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings
Jun 06
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?
May 07Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 07This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid
Sep 15Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?
Aug 12Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest
Jun 11If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late
Mar 19What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?
Mar 01Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?
Jan 23
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company
Jan 05Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 18Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like
Dec 01Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?
Oct 19Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?
Sep 14I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut
Aug 24Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects
Aug 03Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)
Jul 09Rentabilidad de los accionistas
| GUFICBIO | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 2.3% | 3.7% | 2.7% |
| 1Y | 59.1% | 56.2% | 44.1% |
Rentabilidad vs. Industria: GUFICBIO superó a la industria Indian Pharmaceuticals, que obtuvo un rendimiento del 47.6% el año pasado.
Rentabilidad vs. Mercado: GUFICBIO superó al mercado Indian, que obtuvo un rendimiento del 46.4% el año pasado.
Volatilidad de los precios
| GUFICBIO volatility | |
|---|---|
| GUFICBIO Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 9.9% |
| 10% least volatile stocks in IN Market | 4.5% |
Precio estable de las acciones: GUFICBIO no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de GUFICBIO (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1970 | 1,628 | Pranav Choksi | www.gufic.com |
Gufic Biosciences Limited fabrica y comercializa principios activos farmacéuticos (API), productos farmacéuticos genéricos y servicios relacionados en India, África, Asia, Europa, Australia, Norteamérica, Sudamérica e internacionalmente. La empresa fabrica principios activos farmacéuticos y medicamentos a granel, como antifúngicos, anestésicos, inmunosupresores y productos intermedios para antifúngicos. Fabrica inyecciones liofilizadas, que incluyen antibióticos, antifúngicos, fármacos cardiacos, contra la infertilidad, antivirales e inhibidores de la bomba de protones.
Resumen de fundamentos de Gufic Biosciences Limited
| Estadísticas fundamentales de GUFICBIO | |
|---|---|
| Capitalización bursátil | ₹31.60b |
| Beneficios(TTM) | ₹861.36m |
| Ingresos (TTM) | ₹8.07b |
36.7x
Ratio precio-beneficio (PE)3.9x
Ratio precio-ventas (PS)¿Está GUFICBIO sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de GUFICBIO | |
|---|---|
| Ingresos | ₹8.07b |
| Coste de los ingresos | ₹3.90b |
| Beneficio bruto | ₹4.17b |
| Otros gastos | ₹3.31b |
| Beneficios | ₹861.36m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 8.59 |
| Margen bruto | 51.67% |
| Margen de beneficio neto | 10.68% |
| Ratio deuda/patrimonio | 59.5% |
¿Cómo se ha desempeñado GUFICBIO a largo plazo?
Ver rendimiento histórico y comparativa